Clinical Management of Cytokine Release Syndrome in CAR-T Therapy
Expert panelists explore approaches to grading and managing Cytokine Release Syndrome (CRS) in CAR-T therapy, discussing effective strategies to mitigate severity and key differences in CRS management protocols between ide-cel and cilta-cel.
Video content above is prompted by the following:
- Cytokine Release Syndrome (CRS) is a major concern in CAR-T therapy. How do you approach the grading and management of CRS?
- Which strategies have you found most effective for reducing the severity of CRS?
- Are there notable differences in CRS management protocols between ide-cel and cilta-cel?
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
